Skip to main content

Table 5 Factors of affecting 5-year cumulative survival rate between MSD and AD

From: Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

Variables5-year cumulative OS5-year cumulative DFS
MSDADMSDAD
Grade II-IV aGVHD
 Yes50.0 ± 35.430.0 ± 17.550.0 ± 35.415.0 ± 13.8
 No54.4. ± 9.078.1 ± 6.744.4 ± 9.373.6 ± 7.1
 P-value0.4740.0020.6050.001
Donor-recipient ABO compatibility
 Compatible66.6 ± 12.855.6 ± 11.467.0 ± 12.850.9 ± 11.6
 Incompatible45.9 ± 11.383.0. ± 7.127.7 ± 10.974.9. ± 8.5
 P-value0.2440.0470.0410.078
Conditioning regimen
 Bu/Cy-based52.3 ± 10.377.6 ± 7.144.1 ± 10.4*69.2 ± 7.9*
 TBI/Cy-based60.8 ± 15.858.7. ± 13.140.5 ± 19.6*58.7 ± 13.1*
 P-value0.7770.0230.8540.093
CMV infection
 Yes44.4 ± 18.960.9 ± 9.515.6 ± 14.2*57.4 ± 9.7*
 No57.2 ± 9.785.0. ± 8.254 ± 9.8*75 ± 9.9*
 P-value0.7480.0330.2350.083
  1. * Estimated value censored